Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oleiferoside D is an oleanane-type triterpenoid saponin isolated from the ethanol extract of the roots of *Camellia oleifera*, commonly known as the oil-seed camellia or tea oil tree. Structurally, it consists of an oleanane aglycone with sugar moieties attached at the C-3 position. In pharmacological evaluations, oleiferoside D has demonstrated moderate in vitro cytotoxic activity against several human tumor cell lines, including A549 (lung cancer), B16 (melanoma), BEL-7402 (hepatocellular carcinoma), and MCF-7 (breast cancer). It is primarily of interest in natural product research as a potential lead compound for antineoplastic therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oleiferoside D.